India city Hyderabad 2020 India city Hyderabad

₹850 crore in Q4

Reading now: 842
www.livemint.com

HYDERABAD : Aurobindo Pharma Limiteds consolidated net profit after JV share and minority interest was up by 45.2 per cent to ₹849.8 crore for the quarter ended March 31, 2020 against ₹585.4 crore during the same quarter in FY '19.

According to a filing with stock exchanges, the drug- maker said the consolidated revenue from operations grew by 16.4 per cent to ₹6,158.4 crore during the quarter under discussion against ₹5292.2 crore in the last quarter of FY '19.

For the full year 2019-20, revenue from operations was at ₹23,098.5 crore witnessing a growth of 18.1 per cent over 2018-19.

The net profit, after JV share and minority interest, jumped by 19.7 per cent to ₹2,831 crore as against ₹2,364. 7 crore in FY '19.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA